rethinkPeptides Search
Menu
Study breakdown

How Common Is Headache Among Psychiatric Outpatients—and Can CGRP Drugs Help?

Retrospective CohortPreliminary evidence
The takeaway

About 14% of psychiatric outpatients had headache diagnoses, and an exploratory case series suggests CGRP-targeted therapies may benefit those with migraine.

14.3%

Prevalence of headache diagnoses among psychiatric outpatients

What the researchers found

14.3% of psychiatric outpatients had headache diagnoses, with the majority managed within psychiatry departments rather than neurology.

Why it matters

Headache in psychiatric patients is often attributed to their mental condition and undertreated. CGRP therapies may offer new options for these patients.

The numbers in context

- 2,525 psychiatric outpatients reviewed; 360 (14.3%) had headache diagnoses

- Headache types: generic headache 56.4%, migraine 25.6%, tension-type 12.8%

- Psychiatry managed 42.5% of headache cases; neurology managed 11.7%

- 7 patients received CGRP antibodies; all had headache improvement

- Mean age of CGRP patients: 48.4 years; 6 of 7 were women

How the study worked

Retrospective chart review of all psychiatric outpatients at a 600-bed Japanese general hospital over one year, with an exploratory CGRP case series.

Who was studied

N=2,525 psychiatric outpatients at a 600-bed Japanese regional hospital, 2023-2024. CGRP case series: 7 patients, mean age 48.4, 6 women.

What this study cannot tell us

Retrospective chart review in a single center. Headache diagnoses via insurance codes may be inaccurate. CGRP case series was exploratory with few patients.

How to read the evidence

Retrospective chart review with exploratory case series. Low evidence level; hypothesis-generating.

When this study was published

Published in 2025 covering April 2023 to March 2025.

The bigger picture

The overlap between headache disorders and psychiatric conditions is common, and CGRP-targeted therapies represent a growing area where neurology and psychiatry intersect.

Questions still open

  • Are psychiatric outpatients being undertreated for primary headache disorders?
  • Could CGRP-targeted therapies improve both headache and psychiatric outcomes?

Common questions

Is headache common in psychiatric patients?
Yes. This study found 14.3% of psychiatric outpatients had headache diagnoses, with migraine and tension-type headache being most common after generic headache labels.
What are CGRP therapies?
CGRP-targeted monoclonal antibodies are newer migraine treatments that block calcitonin gene-related peptide, a key molecule in migraine pathways.

Read the original research

Characteristics and management of headache among psychiatric outpatients at a Japanese general hospital: A retrospective study with an exploratory CGRP case series.

PCN reports : psychiatry and clinical neurosciences, 4(4), e70235

Citation

Otani, Kyohei; Imbe, Nobuyasu; Shindo, Ryota. (2025). Characteristics and management of headache among psychiatric outpatients at a Japanese general hospital: A retrospective study with an exploratory CGRP case series.. PCN reports : psychiatry and clinical neurosciences, 4(4), e70235. https://doi.org/10.1002/pcn5.70235